248 patients with blood pressures of 130/80 mm Hg or higher despite treatment with at least three antihypertensive agents were randomized to baxdrostat once daily for 12 weeks vs. placebo. The aldosterone synthase inhibitor generated dose-related reductions in blood pressure of 8 to 11 mmHg vs. placebo.